North America Advanced Medical Stopcock Market to Grow at a CAGR of 3.7% to reach US$ 430.56 million by from 2022 to 2028

North America Advanced Medical Stopcock Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Low-Pressure Stopcocks, Medium Pressure Stopcocks, and High-Pressure Stopcocks) and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Homecare)  

  • Report Code : TIPRE00004651
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 128
Buy Now

The North America advanced medical stopcock market is expected to grow from US$ 335.94 million in 2021 to US$ 430.56 million in 2028; it is estimated to grow at a CAGR of 3.7%  from 2022 to 2028.

A stopcock is a ball valve that is used to control the flow of a liquid or gas in laboratories. These are available in different types, among which a three-way stopcock is made of polycarbonate and has numerous channels for multiple infusion therapy. It is mainly used in intensive therapy units (ITU) and all ward regions where intra-arterial and intra-venous systems are used during different procedures. The growth of the North America advanced medical stopcock market is attributed to the factors such as the growing incidence of chronic diseases and a surge in the number of surgical procedures. However, safety concerns regarding stopcocks are hindering the market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

North America Advanced Medical Stopcock Market: Strategic Insights

north-america-advanced-medical-stopcock-market
Market Size Value inUS$ 335.94 Million in 2021
Market Size Value byUS$ 430.56 Million in 2028
Growth rateCAGR of 3.7%  from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Mexico Advanced Medical Stopcock Market Revenue and Forecast to 2028 (US$ Million)

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Growing Incidence of Chronic Diseases

According to the 2022 statistics of the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six in ten Americans suffer from at least one chronic disease, such as heart disease, stroke, cancer, or diabetes. Additionally, as per the Canadian Chronic Disease Surveillance System, in 2018, 73% of individuals aged 65 or more suffered from at least one chronic disease. In addition, the severity of chronic diseases can be avoided by taking some measures at the initial stage of the diagnosis. The treatment for chronic diseases includes medication, intravenous therapies, or surgical procedures. Infusion therapy is often used in the treatment of many chronic diseases, such as heart failure, cancer, chronic lung diseases, stroke, diabetes, and chronic kidney disease. These treatments require infusion pumps, which is a medical device that consists of a stopcock. It is used to deliver fluids, such as nutrients and medications, including antibiotics, insulin or other hormones, chemotherapy drugs, and pain relievers, into a patient's body in precise amounts. Medical stopcocks are widely used in healthcare settings to deliver infusion therapy to patients of all ages. Moreover, according to the Centers for Disease Control and Prevention (CDC), in the US, in 2019, ~1,752,735 new cases of cancer were reported, and ~599,589 patients died of cancer. Additionally, as per the Globocan 2020, in 2020, there were ~195,499 new cases of cancer in Mexico, and ~90,222 people died due to cancer. Hence, advanced medical stopcocks are widely used during the procedure of chemotherapy to control the dosage of intravenous medicines. Thus, the increasing incidences of chronic diseases are driving the North America advanced medical stopcock market.

The rising number of COVID-19 patients led to a positive impact on the market. In 2021, the US FDA authorized an emergency use authorization (EUA) monoclonal antibody Intravenous (IV) therapy for COVID-19 patients suffering from mild to moderate symptoms. IV therapy administers medicines directly into the patient’s bloodstream with the help of stopcocks. Monoclonal antibodies block viral attachment and entry into human cells to neutralize SARS-CoV-2. Also, in November 2020, the FDA approved a EUA for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19. Also, IV vitamin drips were administered to COVID-19 patients for faster recovery. Thus, the growing number of FDA-approved infusion therapy and IV drips for the treatment of COVID-19 is supporting the North America advanced medical stopcock market.

Type-Based Insights

Based on type, the North America advanced medical stopcock market is segmented into low-pressure stopcocks, medium-pressure stopcocks, and high-pressure stopcocks. The low-pressure stopcocks segment held the largest share of the market in 2021, and it is expected to grow at a rapid rate during the forecast period.

North America Advanced Medical Stopcock Market, by Product – 2021 and 2028

medical-device
North America Advanced Medical Stopcock Market, by Product – 2021 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

End User-Based Insights

Based on end user, the North America advanced medical stopcock market is segmented into hospitals & clinics, homecare, and ambulatory surgery centers. The hospitals & clinics segment held the largest share of the market in 2021, and it is expected to register the highest CAGR during the forecast period.

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Various companies in the North America advanced medical stopcock market focus on the collaboration strategy to enlarge their clientele, which, in turn, helps them maintain their brand name across the world.

North America Advanced Medical Stopcock Market – by Type

  • Low-Pressure Stopcocks
  • Medium-Pressure Stopcocks
  • High-Pressure Stopcocks

North America Advanced Medical Stopcock Market – by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • Homecare

North America Advanced Medical Stopcock Market – by Country

  • US
  • Canada
  • Mexico

Company Profiles

  • B. Braun Melsungen AG
  • Smiths Medical Inc
  • Nipro Corp
  • Elcam Medical Group Co
  • Merit Medical Systems Inc
  • CODAN US Corp
  • Nordson Corp
  • Cook Medical LLC
  • JCM MED SaRL
  • Utah Medical Products Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Canada, Mexico, United States

Frequently Asked Questions


What is medical stopcock?

Stopcocks are devices used to direct the flow of fluid through an infusion system while allowing multiple fluids to be connected. Turning an exterior handle allows the clinician to choose the specific fluid or medication to flow at a given time. Stopcocks must meet many requirements of industry standards, such as flow rate, high- or low-pressure resistance, chemical resistance to lipid-based solutions, sterilization compatibility, dead space, and handle-rotating torque.

What are the driving factors for the North America advanced medical stopcock market?

Key factors that are driving the growth of the North America advanced medical stopcock market over years are growing incidence of chronic diseases and surge in number of surgical procedures.

Which type led the market?

The low-pressure stopcocks segment dominated the North America advanced medical stopcock market and held the largest market share of 56.08% in 2021.

Which end user held the largest share in the North America advanced medical stopcock market?

The hospitals & clinics segment dominated the North America advanced medical stopcock market and accounted for the largest revenue share of 51.16% in 2021

Who are the key players in the North America advanced medical stopcock market?

The anal irrigation systems market majorly consists of the players such B. Braun Melsungen AG, Smiths Medical Inc, Nipro Corp, Elcam Medical Group Co, Merit Medical Systems Inc, CODAN US Corp, Nordson Corp, Cook Medical LLC, JCM MED SaRL, Utah Medical Products Inc among others.

What is the market scenario of North America advanced medical stopcock?

North America advanced medical stopcock market is segmented by countries into US, Canada, and Mexico. The US is experiencing rapidly growing prevalence and incidences of chronic conditions such as cancer and infectious diseases. The government of the country is also involved in taking various measures to control the rising prevalence of chronic disorders. The country also spends more on healthcare expenditure that enables to the introduction of various innovative procedures for the treatment of several chronic conditions. Hence, owing to the above-mentioned factors, the growth of US advanced medical stopcock market contributed the largest market share during the forecast period.

The List of Companies - North America Advanced Medical Stopcock Market

  1. B. Braun Melsungen AG
  2. Smiths Medical Inc
  3. Nipro Corp
  4. Elcam Medical Group Co
  5. Merit Medical Systems Inc
  6. CODAN US Corp
  7. Nordson Corp
  8. Cook Medical LLC
  9. JCM MED SaRL
  10. Utah Medical Products Inc          

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Advanced Medical Stopcock Market